Recombinant Interleukin-1 Receptor Antagonist Conjugated to Superparamagnetic Iron Oxide Nanoparticles for Theranostic Targeting of Experimental Glioblastoma

Por Maxim A. Shevtsov, Boris P. Nikolaev, Ludmila Y. Yakovleva, Anatolii V. Dobrodumov, Alexander V. Zhakhov, Anastasiy L. Mikhrina, Emil Pitkin, Marina A. Parr, Valerii I. Rolich, Andrei S. Simbircev, Alexander M. Ischenko
Publicado em 2015-01-01